Li L - Search Results

1

Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma: a retrospective study.

Jiang C, Liu J, Li L, Kosik RO, Su M, Zou L, Tian R. Jiang C, et al. Among authors: li l. Nucl Med Commun. 2017 Nov;38(11):937-947. doi: 10.1097/MNM.0000000000000731. Nucl Med Commun. 2017. PMID: 28858180

2

Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma.

Jing XM, Zhang ZH, Wu P, Zhang SC, Ren YR, Xiong ZJ, Wei W, Luo L, Li L. Jing XM, et al. Among authors: li l. Leuk Res. 2016 Aug;47:26-31. doi: 10.1016/j.leukres.2016.05.004. Epub 2016 May 12. Leuk Res. 2016. PMID: 27239738

3

A pulmonary chondromatous hamartoma resembling multiple metastases in the (18)F-FDG PET/CT scan.

Li L, Jiang C, Tian R. Li L, et al. Hell J Nucl Med. 2016 May-Aug;19(2):176-8. doi: 10.1967/s002449910376. Epub 2016 Jun 22. Hell J Nucl Med. 2016. PMID: 27331216

4

Effectiveness of pegaspargase, gemcitabine, and oxaliplatin (P-GEMOX) chemotherapy combined with radiotherapy in newly diagnosed, stage IE to IIE, nasal-type, extranodal natural killer/T-cell lymphoma.

Wei W, Wu P, Li L, Zhang ZH. Wei W, et al. Among authors: li l. Hematology. 2017 Jul;22(6):320-329. doi: 10.1080/10245332.2016.1264163. Epub 2016 Dec 5. Hematology. 2017. PMID: 27917702 Free article.

5

Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.

Wang H, Shen G, Jiang C, Li L, Cui F, Tian R. Wang H, et al. Among authors: li l. PLoS One. 2018 Mar 20;13(3):e0194435. doi: 10.1371/journal.pone.0194435. eCollection 2018. PLoS One. 2018. PMID: 29558489 Free PMC article.

6

Bombesin-functionalized superparamagnetic iron oxide nanoparticles for dual-modality MR/NIRFI in mouse models of breast cancer.

Li L, Wu C, Pan L, Li X, Kuang A, Cai H, Tian R. Li L, et al. Among authors: li x. Int J Nanomedicine. 2019 Aug 21;14:6721-6732. doi: 10.2147/IJN.S211476. eCollection 2019. Int J Nanomedicine. 2019. PMID: 31686805 Free PMC article.

7

Development and validation of an ¹⁸F-FDG PET radiomic model for prognosis prediction in patients with nasal-type extranodal natural killer/T cell lymphoma.

Wang H, Zhao S, Li L, Tian R. Wang H, et al. Among authors: li l. Eur Radiol. 2020 Oct;30(10):5578-5587. doi: 10.1007/s00330-020-06943-1. Epub 2020 May 20. Eur Radiol. 2020. PMID: 32435928

8

Current status and quality of radiomics studies in lymphoma: a systematic review.

Wang H, Zhou Y, Li L, Hou W, Ma X, Tian R. Wang H, et al. Among authors: li l. Eur Radiol. 2020 Nov;30(11):6228-6240. doi: 10.1007/s00330-020-06927-1. Epub 2020 May 29. Eur Radiol. 2020. PMID: 32472274

9

New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer.

Li X, Cai H, Wu X, Li L, Wu H, Tian R. Li X, et al. Among authors: li l. Front Chem. 2020 Dec 1;8:583309. doi: 10.3389/fchem.2020.583309. eCollection 2020. Front Chem. 2020. PMID: 33335885 Free PMC article. Review.

10

Rituximab treatment strategy for patients with diffuse large B-cell lymphoma after first-line therapy: a systematic review and meta-analysis.

Ren YR, Jin YD, Zhang ZH, Li L, Wu P. Ren YR, et al. Among authors: li l. Chin Med J (Engl). 2015 Feb 5;128(3):378-83. doi: 10.4103/0366-6999.150111. Chin Med J (Engl). 2015. PMID: 25635435 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,970 results

Search Page

Filters